These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception. DuBrock HM, Del Valle KT, Krowka MJ. Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916 [Abstract] [Full Text] [Related]
13. Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension. Raevens S, Geerts A, Devisscher L, Van Vlierberghe H, Van Steenkiste C, Colle I. Acta Gastroenterol Belg; 2021 Jun; 84(1):95-99. PubMed ID: 33639700 [Abstract] [Full Text] [Related]
14. Sex Differences in Portopulmonary Hypertension. DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ. Chest; 2021 Jan; 159(1):328-336. PubMed ID: 32798521 [Abstract] [Full Text] [Related]
16. Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates. Hayashi R, Kogiso T, Kikuchi N, Yamamoto K, Nakamura S, Egawa H, Hagiwara N, Tokushige K. PLoS One; 2022 Jun; 17(4):e0267125. PubMed ID: 35439259 [Abstract] [Full Text] [Related]